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Abstract
Purpose—We examined parents’ and adolescents’ preferences regarding potential strategies to
increase HPV vaccination rates, including offering the vaccine in alternative settings, concomitant
administration of vaccines, and optimizing the structure of vaccination medical visits.
Methods—A national sample of US parents of adolescent males ages 11–17 years (n=506) and
their sons (n=391) completed online surveys in August and September 2010. We used analysis of
variance for mixed designs to examine preferences for vaccination settings.
Results—Parents and sons were most comfortable with sons getting HPV vaccine in a doctor’s
office. Parents of sons who had not visited their regular healthcare providers in the last year were
more comfortable with sons getting HPV vaccine at a public clinic (p<0.001) or school (p<0.05)
compared to parents whose sons had recent visits. Results from the son survey showed a similar
pattern. Parents and sons reported moderate levels of acceptability of concomitant administration.
They most preferred to have the three HPV vaccine shots administered during brief nurse visits.
Conclusion—Offering HPV vaccine in alternative settings and administering it with other
recommended adolescent vaccines may increase uptake among adolescent males. Parents and sons
may prefer for HPV vaccination to occur during brief nurse visits.
© 2012 Society for Adolescent Medicine. Published by Elsevier Inc. All rights reserved.
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Implications and Contribution
Offering HPV vaccine in alternative settings and administering it with other recommended adolescent vaccines may increase uptake
among adolescent males. To our knowledge, this study provides the first national data on this range of HPV vaccine delivery
preferences for adolescent males.
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Introduction
Since 2006, guidelines have recommend routine provision of quadrivalent HPV vaccine for
11–12 year-old females with catch-up vaccination for females through age 26 (1).
Guidelines also now recommend routine vaccination for males ages 11–12 with catch-up
vaccination to age 21 (2). Despite recommendations, only 49% of 13–17 year-old females
and about 2% of adolescent males have received any doses of HPV vaccine, though
estimates for males precede the recommendation for routine male vaccination (3, 4). One
potentially effective strategy to increase these rates is to offer HPV vaccine in alternative
settings, such as schools and pharmacies. School-located HPV vaccination programs have
been highly effective in Australia and the United Kingdom (5–7) and have just started to
develop in the United States (US) (8). Pharmacies represent a setting beyond the traditional
medical home that may also help improve vaccination rates (9). As of 2008, 49 states
allowed pharmacists to vaccinate adults and 27 allowed some form of adolescent
vaccination (10). Most pharmacy representatives believe retail pharmacies will expand
adolescent vaccination services in the future (11).
Other aspects of vaccine delivery, such as concomitant administration of vaccines and
optimizing the structure of vaccination medical visits, may also help increase HPV
vaccination. HPV vaccine can be administered at the same visit as other appropriate
vaccines (1), and our past research showed that adolescent females who had received
meningococcal vaccine were more likely to have also received HPV vaccine (12).
Administering HPV vaccine during adolescents’ medical visits when healthcare providers
deliver other services (e.g., routine screenings or physical exams) is a standard practice that
provides another possible avenue for increasing vaccination.
Such strategies could be particularly important to increasing HPV vaccination among
adolescent males. Adolescent males, especially older adolescents, may receive fewer
outpatient healthcare visits overall and fewer preventive care visits compared to adolescent
females (13). Physicians may also be less likely to recommend HPV vaccination to male
adolescents compared to females, though most providers indicate they would recommend
vaccination for males (14).
Limited research has examined parents’ and adolescents’ vaccine delivery preferences.
Parents have expressed modest to high acceptance of school-located vaccination for
adolescents (including HPV vaccination), with less acceptance of pharmacy-located
vaccination (15–18). Adolescents have expressed modest acceptance for both school- and
pharmacy-located vaccination (18). Many parents and adolescents would be willing for the
adolescents to receive multiple vaccines during the same medical visit (18). For vaccines
requiring three medical visits, such as HPV vaccine, most parents have indicated they prefer
to have at least one of the visits involve other adolescent healthcare services (19). We are
not aware of any studies, however, examining this range of vaccine delivery preferences
among a national sample of parents and adolescents. In the current study, we examined HPV
vaccine delivery preferences of US parents and their adolescent sons.
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The HPV Immunization in Sons (HIS) study examined HPV vaccine attitudes and beliefs of
parents and their adolescent sons ages 11–17 years (4). We recruited parents from a national
panel of US households maintained by an online survey company (Knowledge Networks).
The survey company used a dual frame approach (list-assisted, random-digit dialing
supplemented by address-based sampling) to sample households into their panel (20). Panel
members in non-Internet households receive a laptop and free internet access for completing
multiple online surveys each month. In households with existing internet access, panel
members receive points for completing surveys that can later be redeemed for small cash
payments. The survey company randomly sampled panel members with sons ages 11–17
years to participate. We asked participating parents to allow their sons to participate in the
study as well. The Institutional Review Board at the University of North Carolina approved
the study.
A total of 1195 parents received email invitations to participate in our study, of whom 752
responded. Of these parents, 73% (n=547) were eligible and completed the parent survey.
We asked parents with multiple sons ages 11–17 to answer questions about their son who
had the most recent birthday and to permit this son to complete the son survey. Over half of
responding parents (56%, n=421) had sons who completed the son survey. Parents and sons
completed surveys in August and September 2010 after providing consent (parents) or
assent (sons) to participate. Parents with existing computer and internet access received
about 1,000 points ($1.00 equivalent) for completing our survey and sons received points
equivalent to $5.
We do not report data on parents whose sons had already received one or more doses of
HPV vaccine (n=12) or vaccinated sons who completed surveys (n=9). We also do not
report data on parents whose sons were home-schooled (n=29) or their sons (n=21), as they
did not receive items about school-located HPV vaccination. Thus, our analytic sample
included 506 parents and 391 sons.
A majority of parents were younger than 45 years of age (61%) and non-Hispanic white
(67%) (Table 1). About half of parents were female (54%), had at least some college
education (56%), and reported a household income of at least $60,000 (50%). Most sons
who completed surveys were non-Hispanic white (61%), with fairly equal distribution
across the three age groups (30% ages 11–12, 38% ages 13–15, and 31% ages 16–17).
About 79% of sons had seen their regular healthcare provider in the last year. Parents and
sons reported moderate levels of overall HPV vaccine acceptability, results we reported
previously (4).
Measures
The parent and son surveys are available online at http://www.unc.edu/~ntbrewer/hpv.htm.
We developed survey items concerning HPV vaccination in alternative settings based on our
previous research among parents with adolescent daughters (15).
Parent and son surveys included corresponding items regarding possible settings for HPV
vaccination. All items started with the phrase, “If you and (son’s name) decided to get him
the HPV vaccine…” for the parent survey and, “If you and your parents decided to get you
the HPV vaccine…” for the son survey. Surveys asked participants how comfortable they
were with the sons getting HPV vaccine in four settings: (a) a local pharmacy or drug store
if it offered the vaccine; (b) the son’s school if it offered the vaccine in a nurse’s office; (c):
a public or community clinic (a clinic where people get medical care at low cost that is not a
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private doctor’s office); and (d) a doctor’s office. A preamble to the items clarified that
comfortable did not mean whether the shots themselves would be painful. All items had a 5-
point response scale ranging from “very uncomfortable” to “very comfortable” (coded 1–5
with higher values indicating greater comfort). Following the pharmacy and school items,
surveys asked what concerns parents and sons would have about sons getting HPV vaccine
in these two settings, as well as what the potential benefits would be. We provided parents
and sons with lists of concerns and potential benefits, from which they could select multiple
answers.
Surveys assessed the types of healthcare visits at which respondents would prefer sons
receive the three-dose HPV vaccine series (if they decided to vaccinate at a doctor’s office):
(a) brief nurse visits for all three shots; (b) longer doctor visits for all three shots that each
include other preventive care services (such as a physical exam or counseling); or (c) a
longer doctor visit that includes the first shot and other preventive care services, and brief
nurse visits for the last two shots (19).
Surveys assessed acceptability of concomitant administration by asking participants how
willing they would be for sons to get other vaccines during the same visit as HPV vaccine
(supposing they had decided to vaccinate and a doctor recommended concomitant
administration). Concomitant administration items had a 5-point response scale ranging
from “definitely not willing” to “definitely willing” (coded 1–5 with higher values
indicating greater willingness). We also collected information on parent and son
demographic characteristics (Table 1).
Data Analysis
We analyzed parent and son data separately, with analyses conducted in SPSS version 17.0
(SPSS Inc., Chicago IL) and SAS Version 9.2 (Cary, NC). Because we thought preferences
may differ depending on sons’ recent healthcare utilization, we conducted a 4 × 2 analysis of
variance for mixed designs to explore the influence of vaccination setting (within subjects, 4
levels) and whether sons had seen their regular healthcare providers in the last year (between
subjects, 2 levels). We used McNemar’s test to determine if concerns and perceived benefits
of school- and pharmacy-located HPV vaccination differed. Statistical tests were two-tailed
with a critical alpha of 0.05.
Results
HPV Vaccination Settings
Parents were more comfortable with their sons getting HPV vaccine at a doctor’s office than
in other settings (Figure 1, panel A). The ratings for doctor’s office (mean=4.58, standard
deviation [SD]=0.79) were higher than for a public clinic (mean=3.08, SD=1.27), school
(mean=2.90, SD=1.36), or pharmacy (mean=2.88, SD=1.27) (all p<0.001). Parents whose
sons had not seen their regular healthcare providers in the last year provided more favorable
ratings of some alternative vaccination settings (interaction, p=0.001). Compared to parents
whose sons had seen their regular healthcare providers in the last year, parents of sons
without recent visits were more comfortable with them getting HPV vaccine at a public
clinic (p<0.001) or school (p<0.05). Results also suggested these parents may have been
somewhat more comfortable with pharmacy-located HPV vaccination (p=0.08) and less
comfortable with their sons getting HPV vaccine at a doctor’s office (p=0.14), though
neither difference reached statistical significance.
Results from the son survey showed the same pattern (Figure 1, panel B). Sons were more
comfortable getting HPV vaccine at a doctor’s office (mean=4.24, SD=0.90) compared to a
public clinic (mean=2.93, SD=1.16), school (mean=2.62, SD=1.33), or pharmacy
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(mean=2.57, SD=1.22) (all p<0.001). We again found a statistically significant interaction
between vaccination setting and whether sons had seen their regular healthcare provider in
the last year (p=0.003). Compared to sons with recent provider visits, sons who had not seen
their regular healthcare providers in the last year were more comfortable getting HPV
vaccine at a public clinic (p<0.05), school (p<0.05), or pharmacy (p<0.05). These sons
appeared to be somewhat less comfortable getting HPV vaccine at a doctor’s office
(p=0.12), though this difference again did not reach statistical significance.
Concerns and Perceived Benefits
Parents expressed similar concerns regarding school- and pharmacy-located HPV
vaccination for their sons (Table 2). The most common concern was wanting their sons’
doctors to keep track of their shots and other health history (school=65%, pharmacy=68%).
Other common concerns included training of staff and wanting to be present during
vaccination. Sons were concerned about embarrassment of getting vaccinated at these
locations, wanting their doctors to keep track of their shots and other health history, training
of staff, and wanting a parent present during vaccination. Both parents and sons expressed
more concern about pharmacies than schools with respect to staff training, while both
groups were more concerned that schools should not provide vaccines and other people
potentially finding out if vaccination occurred at schools (all p<0.05).
Parents perceived the main benefit of school- and pharmacy-located HPV vaccination for
their sons would be its convenience (school=36%, pharmacy=37%) (Table 3). Sons
indicated similar perceived benefits as parents regarding school- and pharmacy-located HPV
vaccination. Both parents and sons more commonly noted these benefits for vaccinating at
schools compared to pharmacies (all p<0.05): the chance for a lot of people to get
vaccinated, sons could go with their friends to get vaccinated, and they would know the
people giving the vaccine. Over 40% of parents and sons perceived no benefits of school- or
pharmacy-located HPV vaccination.
Vaccine Administration
Parents (40%) and sons (67%) most preferred brief nurse visits for all three HPV vaccine
shots, if sons were going to receive them at a doctor’s office. Fewer preferred a longer
doctor visit for the first shot (that included other preventive services) followed by brief nurse
visits for the last two shots (parents=39%, sons=16%) or longer doctor visits for all three
shots that each included other preventive care services (parents=19%, sons=14%). A few
parents (2%) and sons (3%) did not indicate their preference.
Most parents (53%) were definitely or probably willing to let their sons receive other
vaccines during the same visit that they received HPV vaccine, if recommended by a doctor.
About 28% of parents were not sure, and 19% were definitely or probably not willing.
About 37% of sons were definitely or probably willing to receive other vaccines during the
same visit as HPV vaccine if recommended by a doctor, 34% were not sure, and 29% were
definitely or probably not willing.
Discussion
HPV vaccination coverage remains suboptimal among adolescent females and is nearly
nonexistent among adolescent males in the US (3, 4). Potential strategies to increase HPV
vaccination include offering the vaccine in alternative settings, concomitant administration
of vaccines, and optimizing the structure of vaccination medical visits. These strategies may
be especially beneficial to adolescent males, since older adolescent males receive fewer
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healthcare visits than females, and healthcare providers may be less likely to recommend
HPV vaccination to adolescent males (13, 14).
Among a national sample of parents and their adolescent sons, we found participants were
most comfortable with sons getting HPV vaccine in a doctor’s office, though they were
moderately comfortable with HPV vaccination in alternative settings. It is not surprising that
comfort levels were highest for HPV vaccination at a doctor’s office since this is the medical
home for most adolescents (17), and over 90% of adolescent females who have received
HPV vaccine did so at a family doctor/general practitioner or pediatrician’s office (21). It is
encouraging that a meaningful number of parents and sons were also comfortable with sons
getting HPV vaccine in alternative settings, particularly in cases where sons had not had
recent healthcare provider visits. These findings correspond with past studies examining
views on school- and pharmacy-located vaccination for adolescents (17, 18). Our results
suggest that offering HPV vaccine in alternative settings may help increase vaccination
among adolescents who do not have regular healthcare visits, an important finding because
low-income adolescents and those without health insurance are less likely to have preventive
care visits (22).
Parents and sons expressed some concerns about HPV vaccination in alternative settings.
Mainly, they were concerned about wanting sons’ doctors to keep track of their
vaccinations, the training of staff administering the vaccines, and wanting parents present
during vaccination. These findings are similar to our previous research examining mothers’
concerns about school-located HPV vaccination for their adolescent daughters (15). Many
parents and sons, however, perceived potential benefits of these same alternative settings,
including convenience and the ability to vaccinate a lot of people. If vaccination programs in
alternative settings are to become more prevalent and successful, they will need to address
concerns and stress the potential benefits.
In this study, parents and sons most preferred brief nurse visits for all three HPV vaccine
doses. These findings are in contrast to past research in the US that found only 8% of
parents preferred three brief nurse visits and most preferred to have at least one visit involve
other adolescent preventive care services (19). This previous study, however, involved a
hypothetical three-dose adolescent vaccine, so our results provide useful insight into
parents’ and sons’ preferences for actual HPV vaccination. Future research is needed to
determine if parents and adolescents are also willing for HPV vaccination to occur during
other types of adolescent care visits (e.g., acute care visits).
Participants in our study reported moderate levels of acceptability of concomitant
administration. This is encouraging because multiple other vaccines have recently been
recommended for adolescents (e.g., tetanus booster, meningococcal, and seasonal influenza
vaccines) (23–25), some of which are required for school entry (26). HPV vaccine can be
administered at the same visit as other adolescent vaccines and doing so will likely increase
the number of adolescents receiving vaccines on schedule (1). It is worth noting that a past
study found higher levels of acceptability of concomitant administration of adolescent
vaccines (18), though participants were recruited during medical visits at primary care
practices and may have been more accepting of health-related behaviors in general.
Study strengths included using a national sample with data from both parents and sons and
examining multiple strategies for increasing HPV vaccination. Although the online panel is
comparable to the US population on many sociodemographic characteristics (27), most
participants were non-Hispanic white and of fairly high socioeconomic status. Data
collection occurred prior to the recommendation for routine HPV vaccination of males (2),
and we do not know the generalizability of findings to adolescent females. Participants may
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have perceived items addressing HPV vaccination in alternative settings as somewhat
hypothetical since school- and pharmacy-located vaccination is not widespread in the US.
The survey also did not address other potentially important issues of HPV vaccination in
alternative settings, such as the process of obtaining consent for vaccination.
Despite these limitations, we believe our findings have potentially important implications.
HPV vaccine uptake may be increased by offering the vaccine in alternative settings and
administering it with other recommended adolescent vaccines. Parents and sons may also
prefer for HPV vaccination to occur during brief nurse visits. Together, these findings offer
valuable insight into parents’ and sons’ preferences regarding HPV vaccination.
Acknowledgments
Funding
Supported in part by a research grant from the Investigator-Initiated Studies Program of Merck Sharp & Dohme
Corp. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck
Sharp & Dohme Corp. Additional support provided by the American Cancer Society (MSRG-06-259-01-CPPB)
and the Cancer Control Education Program at UNC Lineberger Comprehensive Cancer Center (R25 CA57726).
Abbreviations
CDC Centers for Disease Control and Prevention
US United States
HIS study HPV Immunization in Sons (HIS) study
SD standard deviation
References
1. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine:
recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR
Recomm Rep. 2007; 56(RR-2):1–24. [PubMed: 17380109]
2. Centers for Disease Control and Prevention (CDC). CDC online newsroom: ACIP recommends all
11–12 year-old males get vaccinated against HPV. 2011. Available at:
http://www.cdc.gov/media/releases/2011/t1025_hpv_12yroldvaccine.html
3. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among
adolescents aged 13 through 17 years --- United States, 2010. MMWR Morb Mortal Wkly Rep.
2011; 60:1117–23. [PubMed: 21866084]
4. Reiter PL, McRee AL, Kadis JA, et al. HPV vaccine and adolescent males. Vaccine. 2011; 29(34):
5595–602. [PubMed: 21704104]
5. Brabin L, Roberts SA, Stretch R, et al. Uptake of first two doses of human papillomavirus vaccine
by adolescent schoolgirls in Manchester: prospective cohort study. BMJ. 2008; 336(7652):1056–8.
[PubMed: 18436917]
6. Brotherton JM, Deeks SL, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus
vaccination coverage in the school-based program in Australia. Commun Dis Intell. 2008; 32(4):
457–61. [PubMed: 19374275]
7. Reeve C, De La Rue S, Pashen D, et al. School-based vaccinations delivered by general practice in
rural north Queensland: an evaluation of a new human papilloma virus vaccination program.
Commun Dis Intell. 2008; 32(1):94–8. [PubMed: 18522312]
8. Hayes, KA.; Entzel, P.; Berger, W., et al. Working Paper. Early lessons learned from extramural
vaccination programs that offer HPV vaccine in US schools.
Reiter et al. Page 7













9. Schaffer SJ, Fontanesi J, Rickert D, et al. How effectively can health care settings beyond the
traditional medical home provide vaccines to adolescents? Pediatrics. 2008; 121 (Suppl 1):S35–45.
[PubMed: 18174319]
10. Rothholz, MC. Pharmacists: access to immunization services. Presentation to the 1st National
Stakeholder Meeting: review of priorities in the National Vaccine Plan. 2008. Available at:
http://www.iom.edu/Activities/PublicHealth/NatVaxPlan/2008-JUL-24.aspx
11. Skiles MP, Cai J, English A, et al. Retail pharmacies and adolescent vaccination--an exploration of
current issues. J Adolesc Health. 2011; 48(6):630–2. [PubMed: 21575825]
12. Reiter PL, McRee AL, Gottlieb SL, et al. Correlates of receiving recommended adolescent
vaccines among adolescent females in North Carolina. Hum Vaccin. 2011; 7(1):67–73. [PubMed:
21263224]
13. Rand CM, Shone LP, Albertin C, et al. National health care visit patterns of adolescents:
implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007; 161(3):
252–9. [PubMed: 17339506]
14. Weiss TW, Zimet GD, Rosenthal SL, et al. Human papillomavirus vaccination of males: attitudes
and perceptions of physicians who vaccinate females. J Adolesc Health. 2010; 47(1):3–11.
[PubMed: 20547286]
15. Kadis JA, McRee AL, Gottlieb SL, et al. Mothers’ support for voluntary provision of HPV vaccine
in schools. Vaccine. 2011; 29(14):2542–7. [PubMed: 21300097]
16. Middleman AB, Tung JS. Urban middle school parent perspectives: the vaccines they are willing
to have their children receive using school-based immunization programs. J Adolesc Health. 2010;
47(3):249–53. [PubMed: 20708563]
17. Middleman AB, Tung JS. At what sites are parents willing to have their 11 through 14-year-old
adolescents immunized? Vaccine. 2010; 28(14):2674–8. [PubMed: 20085835]
18. Rand CM, Humiston SG, Schaffer SJ, et al. Parent and adolescent perspectives about adolescent
vaccine delivery: practical considerations for vaccine communication. Vaccine. 2011; 29(44):
7651–8. [PubMed: 21839793]
19. Dempsey AF, Singer D, Clark SJ, Davis MM. Parents’ views on 3 shot-related visits: implications
for use of adolescent vaccines like human papillomavirus vaccine. Acad Pediatr. 2009; 9(5):348–
52. [PubMed: 19487172]
20. Dennis, JM. KnowledgePanel design summary. 2011. Available at:
http://www.knowledgenetworks.com/knpanel/docs/KnowledgePanel(R)-Design-Summary-
Description.pdf
21. Reiter PL, Cates JR, McRee AL, et al. Statewide HPV vaccine initiation among adolescent females
in North Carolina. Sex Transm Dis. 2010; 37(9):549–56. [PubMed: 20414146]
22. Irwin CE Jr, Adams SH, Park MJ, et al. Preventive care for adolescents: few get visits and fewer
get services. Pediatrics. 2009; 123(4):e565–72. [PubMed: 19336348]
23. Bilukha OO, Rosenstein N. National Center for Infectious Diseases, Centers for Disease Control
and Prevention (CDC). Prevention and control of meningococcal disease. recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005; 54(RR-7):
1–21. [PubMed: 15917737]
24. Broder KR, Cortese MM, Iskander JK, et al. Preventing tetanus, diphtheria, and pertussis among
adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines
recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR
Recomm Rep. 2006; 55(RR-3):1–34.
25. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines:
recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR
Recomm Rep. 2010; 59(RR-8):1–62. [PubMed: 20689501]
26. Immunization Action Coalition. State information. State mandates on immunization and vaccine-
preventable diseases. 2011. Available at: http://www.immunize.org/laws/
27. Baker, LC.; Bundorf, MK.; Singer, S., et al. Validity of the survey of health and internet and
Knowledge Network’s panel and sampling. 2003. Available at:
http://www.knowledgenetworks.com/ganp/docs/Appendix%20Survey%20of%20Health%20and
%20the%20Internet.pdf
Reiter et al. Page 8













Reiter et al. Page 9














Comfort with sons getting HPV vaccine in different settings, United States, 2010. Responses
by parents (panel A) and sons (panel B). Response scale ranged from “very uncomfortable”
(coded as 1) to “very comfortable” (5). Bars indicate the standard errors.
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Table 1




 Female 271 (54)
 Male 235 (46)
Age (Years)
 <45 309 (61)
 ≥45 197 (39)
Race/Ethnicity
 White, Non-Hispanic 340 (67)
 African American, Non-Hispanic 62 (12)
 Hispanic 78 (15)
 Other 26 (5)
Education
 High School Degree or Less 223 (44)
 Some College or More 283 (56)
Household Income
 <$60,000 253 (50)
 ≥$60,000 253 (50)
Son Characteristicsa
Age (Years)
 11–12 119 (30)
 13–15 149 (38)
 16–17 123 (31)
Race/Ethnicity
 White, Non-Hispanic 240 (61)
 African American, Non-Hispanic 48 (12)
 Hispanic 63 (16)
 Other 40 (10)
Son Saw Regular Healthcare Provider in Last Year
 No 83 (21)
 Yes 308 (79)
a
Data collected during parent survey, but we report data only for those sons who completed their own surveys. Sons who completed surveys were
similar to non-completers on these characteristics (all p>0.05).
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